Leo Brokerage’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$2.49M Buy
32,272
+8,640
+37% +$689K 0.28% 58
2023
Q1
$1.96M Buy
+23,632
New +$1.96M 0.29% 66
2022
Q2
$554K Sell
8,958
-2,647
-23% -$164K 0.15% 91
2022
Q1
$690K Buy
+11,605
New +$742K 0.11% 123

Other funds holding GILD

Leo Brokerage's GILD Position: Q2 2023 in Review

Leo Brokerage increased its Gilead Sciences (GILD) stake by 37% in Q2 2023, buying an estimated $689K and bringing the position to 32,272 shares worth $2.49M. The position accounts for 0.28% of the portfolio, ranked #58.

Leo Brokerage first reported a position in GILD in Q1 2022 and has held it in 4 quarters since. 1,702 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

  • Leo Brokerage held 32,272 shares of Gilead Sciences worth $2.49M as of Q2 2023.
  • Leo Brokerage bought 8,640 Gilead Sciences shares in Q2 2023, an estimated $689K.
  • Gilead Sciences made up 0.28% of Leo Brokerage's portfolio in Q2 2023, its #58 holding.
  • Leo Brokerage first reported a position in Gilead Sciences in Q1 2022 and has held it in 4 quarters since.
  • 1,702 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on Leo Brokerage's 13F filing for Q2 2023, filed 25 Jul 2023.